MEDICAID-HEP C PHARMACEUTICALS

Amends the Medical Assistance Article of the Illinois Public Aid Code. Requires the Department of Healthcare and Family Services to develop and pay a monthly supplemental capitation payment for all high cost specialty pharmaceuticals and medical treatments, including, but not limited to, curative Hepatitis C pharmaceuticals. Provides that the supplemental capitation payments shall be made to all impacted capitated managed care organizations that follow the Department's clinical coverage guidelines for pharmaceuticals and treatments covered by a supplemental capitation payment; and that the supplemental capitation payment must be made by the Department within 60 days of receipt of data from the impacted managed care organization. Provides that for all new high cost specialty pharmaceuticals and medical treatments not previously contemplated and included within existing capitation rates, the Department shall be responsible for the full cost until clinical coverage guidelines and supplemental capitation payments are in place. Effective immediately.